Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business. The technologies, used in the production of biologics and medical devices and for industrial applications,
Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...
Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...
The quest for improved health and well-being often leads us to explore innovative solutions within our homes. Among such ...
M health care spinoff Solventum says it will sell the business unit to Massachusetts-based Thermo Fisher Scientific Inc.
A good first step to address this is to use an air purifier. These fundamentally simple appliances not only trap airborne ...
A transaction is expected to value the filtration business between $3.5 billion and $4 billion, the people added.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback